Cargando…
Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort
BACKGROUND AND AIMS: A method for assessment of liver fibrosis and cirrhosis without the need for a liver biopsy is desirable. Microfibrillar-associated protein 4 (MFAP4) is a suggested biomarker for identification of high-risk patients with severe fibrosis stages. This study aimed to examine associ...
Autores principales: | Sækmose, Susanne Gjørup, Mössner, Belinda, Christensen, Peer Brehm, Lindvig, Kristoffer, Schlosser, Anders, Holst, René, Barington, Torben, Holmskov, Uffe, Sorensen, Grith Lykke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604125/ https://www.ncbi.nlm.nih.gov/pubmed/26460565 http://dx.doi.org/10.1371/journal.pone.0140418 |
Ejemplares similares
-
Enzyme-Linked Immunosorbent Assay Characterization of Basal Variation and Heritability of Systemic Microfibrillar-Associated Protein 4
por: Sækmose, Susanne Gjørup, et al.
Publicado: (2013) -
Circadian, Week-to-Week, and Physical Exercise-Induced Variation of Serum Microfibrillar-Associated Protein 4
por: Sækmose, Susanne Gjørup, et al.
Publicado: (2021) -
Localization of Microfibrillar-Associated Protein 4 (MFAP4) in Human Tissues: Clinical Evaluation of Serum MFAP4 and Its Association with Various Cardiovascular Conditions
por: Wulf-Johansson, Helle, et al.
Publicado: (2013) -
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
por: Mölleken, Christian, et al.
Publicado: (2019) -
Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar‐associated protein 4
por: Madsen, Bjørn S., et al.
Publicado: (2020)